Zeptometrix NATtrol™ SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock

Description

Designed to evaluate the performance of nucleic acid tests for determination of the presence of SARSCoV-2 Variant B.1.351 RNA.

NATtrol™ SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock is formulated with purified, intact viral particles. that have been chemically modified to render them non-infectious and refrigerator stable. Each vial contains 1.0 mL of NATtrol™ SARS-CoV-2 Variant B.1.351 stock in a proprietary matrix with a target concentration.

INTENDED USE:

• NATtrol™ SARS-CoV-2 Variant B.1.351 stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARSCoV-2 Variant B.1.351 RNA.
• NATtrol™ SARS-CoV2 Variant B.1.351 stock enables laboratories to monitor test variation, lot-to-lot test kit performance, operator variation, and can provide assistance in identifying random or systemic error.

Specifications

• Certifications/Compliance: ISO 13485
• Content And Storage: 2°C to 8°C
• Concentration: 1,000,000 copies/mL²
• Type: Stock
• For Use With (Application): Evaluate performance of molecular tests, verification of assays, training of laboratory personnel and to monitor assay-kit lot performance
• Quantity: 1 mL

RUO only.